Decheng Capital

Offices: Shanghai (China), Menlo Park (United States), New York (United States)

Stages: Series A, Series B, Series C

Markets: Biopharma, Medical Devices, Diagnostics, Life Science Tools, HealthTech, Digital Health, Agricultural BioTech, Industrial BioTech